Novo Nordisk CEO Talks Weight Loss Drug Supply
Bloomberg Talks
00:00
Exploring Long-Term Use and Administration Routes of Weight Loss Drugs
Exploring the debate around the continued use of weight loss drugs like GLP-1s, questioning if they are permanent solutions or if discontinuation is feasible post-achievement of weight loss goals. The chapter also touches on personalized medicine, varying patient needs, and the evolving landscape of medication administration from injectables to oral pills.
Transcript
Play full episode
